The training program in Cardiovascular Research at Brigham and Women's Hospital aims to provide excellent post-doctoral training to individuals with M.D., Ph.D. or combined degrees to prepare them for careers in investigative cardiology. The three themes of focus for this training program include 1) Myocardial Cellular and Molecular Biology and Genetics, 2) Vascular Cell and Molecular Biology, and 3) Translational/Clinical Research. We strive to prepare physician scientists to develop independent research programs, obtain faculty positions, and acquire peer-reviewed funding. The Cardiovascular Division at Brigham and Women's Hospital has substantial offerings available for trainees, ranging from core laboratories within Brigham and Women's Hospital, formal educational opportunities at Harvard School of Public Health, and ample resources within the individual laboratories of faculty. The Cardiovascular Division provides a structured program for each trainee including orientation lectures, advanced course work, multiple research group meetings and individualized research experiences. The Research Progress seminar, an annual Fellow's Poster Session, and Cardiovascular Grand Rounds serve to highlight and support the work of the post-doctoral trainees. Each trainee works closely under the supervision of a faculty mentor throughout their training. Progress of trainees is closely monitored by the Fellowship Advisory Board, which oversees the program. In this application we propose to continue our longstanding record (documented within) or preparing a talented pool of fellows for successful academic careers.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007604-29
Application #
8494656
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Scott, Jane
Project Start
1985-07-01
Project End
2015-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
29
Fiscal Year
2013
Total Cost
$679,596
Indirect Cost
$48,674
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Vaduganathan, Muthiah; Nagarur, Amulya; Qamar, Arman et al. (2017) Availability and Use of Shared Data From Cardiometabolic Clinical Trials. Circulation :
Wadhera, Rishi K; Bhatt, Deepak L (2017) Taking the ""Public"" Out of Public Reporting of Percutaneous Coronary Intervention. JAMA 318:1439-1440
Blumenthal, Daniel M; Olenski, Andrew R; Yeh, Robert W et al. (2017) Sex Differences in Faculty Rank Among Academic Cardiologists in the United States. Circulation 135:506-517
Wadhera, Rishi K (2017) Cardiovascular Medicine Amid EvolvingĀ Health Policy: Time to Train a Generation of Policy Leaders. J Am Coll Cardiol 70:2201-2204
Wadhera, Rishi K; Anderson, Jordan D; Yeh, Robert W (2017) High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications. Curr Heart Fail Rep 14:514-518
Bergmark, Brian A; Cannon, Christopher P; White, William B et al. (2017) Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial. Diabetes Obes Metab 19:962-969
Kithcart, Aaron P; Libby, Peter (2017) Unfriendly Fire From Neutrophils Promiscuously Potentiates Cardiovascular Inflammation. Circ Res 121:1029-1031
Carreras, Edward T; Barghash, Maya; Givertz, Michael M et al. (2017) A heart within a heart. Catheter Cardiovasc Interv 89:1239-1241
Wadhera, Rishi K; Stewart, Garrick C; O'Gara, Patrick T (2017) A 52-Year-Old Man With Unheralded Syncope. JAMA Cardiol 2:1394-1395
Stefanescu Schmidt, Ada C; Kereiakes, Dean J; Cutlip, Donald E et al. (2017) Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy). Circulation 135:1720-1732

Showing the most recent 10 out of 121 publications